Sensory Cloud Shows Positive Phase 2a Results for Chronic Cough
Daily treatment with SC0023 yielded treatment efficacy 53.5% ± 19.2% relative to baseline in 24-hour daily cough rate and 19.5% ± 6.2% placebo effect Cough...
Tag : biopharma company
Innovent Presents Phase 3 DREAMS-1 Study of Mazdutide at ADA 85th
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and...
Onc.AI to Present Breakthrough AI Model at AACR 2025
Serial CTRS (CT Response Score) improves prediction of overall survival compared to RECIST 1.1 and Tumor Volume Change in advanced NSCLC Onc.AI, a digital health...